Tang Capital Management’s Biohaven BHVN Stock Holding History

Tang Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-140,000	Closed	-$1.58M	–	56
2025 Q4	$1.58M	Hold	140,000	–	–	0.08%	68
2025 Q3	$2.1M	Hold	140,000	–	–	0.08%	125
2025 Q2	$1.98M	Hold	140,000	–	–	0.1%	118
2025 Q1	$3.37M	Hold	140,000	–	–	0.19%	94
2024 Q4	$5.23M	Hold	140,000	–	–	0.35%	69
2024 Q3	$7M	Hold	140,000	–	–	0.5%	58
2024 Q2	$4.86M	Hold	140,000	–	–	0.49%	59
2024 Q1	$7.66M	Hold	140,000	–	–	0.8%	44
2023 Q4	$5.99M	Hold	140,000	–	–	0.55%	47
2023 Q3	$3.64M	Hold	140,000	–	–	0.51%	52
2023 Q2	$3.35M	Hold	140,000	–	–	0.49%	55
2023 Q1	$1.91M	Hold	140,000	–	–	0.29%	73
2022 Q4	$1.94M	Buy	+140,000	New	+$1.98M	0.28%	59

Other funds holding BHVN

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $242M AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tang Capital Management's BHVN Position: Q1 2026 in Review

Tang Capital Management sold out of Biohaven (BHVN) in Q1 2026, closing a stake of 140,000 shares — an estimated $1.58M sold.

Tang Capital Management first reported a position in BHVN in Q4 2022 and held it in 13 quarters. The position peaked at $7.66M in Q1 2024. 277 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

Tang Capital Management reported no remaining Biohaven position as of Q1 2026 after selling out during the quarter.
Tang Capital Management sold 140,000 Biohaven shares in Q1 2026, an estimated $1.58M.
Tang Capital Management first reported a position in Biohaven in Q4 2022 and held it in 13 quarters.
Tang Capital Management's Biohaven position peaked at $7.66M in Q1 2024.
277 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Tang Capital Management's 13F filing for Q1 2026, filed 15 May 2026.